Development History After the discovery of GHK-CU in the 1980s, researchers quickly identified limitations: the peptide was fragile, broke down when exposed to other skincare ingredients, and had limited penetration depth
#b12 #b12shots #b12deficiency #b12injections #b12benefits #wellness | Viliosh Aesthetics Clinic Cork & Wexford
What Makes AOD 9604 Unique
Our topical GHK-Cu serum delivers the regenerative power of copper peptide directly to skin
doi: 10.1038/clpt.2010.57
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction